Which peptides are in this family?
-
AOD-9604hGH Fragment 176-191
Growth hormone fragment studied for weight management. Not licensed in the UK; its largest human trial showed no significant weight-loss benefit.
ModerateNot licensed in the UK -
CJC-1295CJC-1295 with DAC
Long-acting growth-hormone-releasing hormone analogue studied for hormone levels in healthy adults. Not licensed in the UK; human evidence is small, short trials.
LimitedNot licensed in the UK -
GHRP-2Pralmorelin
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK; Japan licenses it only as a diagnostic test. No trial shows a health benefit.
LimitedNot licensed in the UK -
GHRP-6Growth hormone-releasing…
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. Human studies are short hormone-response and diagnostic work; no trial shows a health benefit.
LimitedNot licensed in the UK -
HexarelinExamorelin
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. In a long-term human study the response faded and IGF-I and body composition did not change.
LimitedNot licensed in the UK -
IpamorelinIPA
Synthetic growth hormone secretagogue studied for growth hormone release. Not licensed in the UK; human evidence is one small pharmacokinetic study.
LimitedNot licensed in the UK -
SermorelinSermorelin acetate
Synthetic growth-hormone-releasing hormone fragment studied in children with growth hormone deficiency. Not licensed in the UK; evidence is mainly from before 2000.
LimitedNot licensed in the UK -
TesamorelinTH9507
Not licensed in the UK. Growth-hormone-releasing hormone analogue studied for visceral fat in HIV-associated lipodystrophy, in randomised trials.
StrongNot licensed in the UK
Best recorded finding for each peptide in this family
Each row grades one recorded finding, not the peptide or the medicine.
| Peptide | UK status | Finding | Evidence grade |
|---|---|---|---|
| AOD-9604 | Not licensed in the UK | Six pooled Phase I/II trials | Moderate |
| CJC-1295 | Not licensed in the UK | Growth hormone and IGF-1 elevation | Limited |
| GHRP-2 | Not licensed in the UK | Adult GH deficiency test, Japan | Limited |
| GHRP-6 | Not licensed in the UK | Phase I pharmacokinetics, nine men | Limited |
| Hexarelin | Not licensed in the UK | Amount-dependent GH, cortisol, prolactin | Limited |
| Ipamorelin | Not licensed in the UK | Healthy male pharmacokinetic study | Limited |
| Sermorelin | Not licensed in the UK | 1999 review, childhood GH deficiency | Limited |
| Tesamorelin | Not licensed in the UK | HIV visceral fat trial | Strong |
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.